Titan Biotech Ltd

Extending its recent rally, Titan Biotech Ltd surged to a fresh all-time high of Rs 410 on 25 Mar 2026, marking a significant milestone in its market journey amid strong technical and fundamental signals.

Titan Biotech Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, reached a new 52-week high of Rs.408.9 on 20 Mar 2026, reflecting a robust rally and sustained momentum over recent sessions.

Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, reached a new all-time high of Rs.408.9 on 20 Mar 2026, reflecting a remarkable surge in its stock price and underscoring its strong performance trajectory over recent periods.

Titan Biotech Ltd has emerged as a standout performer in the Specialty Chemicals sector, delivering an extraordinary 334.04% return over the past year, vastly outperforming the Sensex which declined by 1.55% during the same period. This micro-cap stock’s remarkable rally has captured investor attention, driven by robust financial results and a favourable market environment.

Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, has reached an all-time high, marking a significant milestone in its market journey. The stock touched an intraday peak of Rs 399, just 0.76% shy of its 52-week high of Rs 400, reflecting sustained investor confidence and strong operational metrics.

Titan Biotech Ltd has reached a new 52-week high, touching Rs.400 today, reflecting a remarkable rally that has propelled the stock to outperform its sector and broader market indices. This milestone underscores the company’s strong momentum amid a challenging market environment.

Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, achieved a significant milestone on 13 Mar 2026 by reaching its all-time high price of Rs.400. This landmark reflects the company’s robust performance across multiple financial and technical parameters, underscoring its strong position within the industry.

Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, reached a new all-time high of Rs.387.95 on 12 Mar 2026, reflecting a remarkable surge in its stock price and underscoring its strong performance across multiple financial and technical parameters.

Titan Biotech Ltd, a key player in the Specialty Chemicals sector, reached a significant milestone on 12 Mar 2026 by hitting a new 52-week high of Rs.386.7. This achievement underscores the stock’s robust momentum, driven by sustained gains and strong quarterly financial performance amid a broader market environment showing mixed trends.

Titan Biotech Ltd, a key player in the Specialty Chemicals sector, surged to a fresh 52-week high of Rs.372.55 on 11 Mar 2026, reflecting robust momentum and sustained gains over recent sessions. This milestone underscores the stock’s remarkable performance amid a challenging broader market environment.

Titan Biotech Ltd, a key player in the Specialty Chemicals sector, reached a new 52-week high of Rs.324.4 on 10 Mar 2026, underscoring a remarkable rally driven by sustained momentum and robust financial performance.

Titan Biotech Ltd, a key player in the Specialty Chemicals sector, surged to a fresh 52-week high of Rs.322 on 9 Mar 2026, reflecting robust momentum amid a volatile market backdrop. This milestone underscores the stock’s impressive rally, outpacing its sector and broader indices over recent sessions.

Titan Biotech Ltd, a prominent player in the Specialty Chemicals sector, has reached an all-time high, marking a significant milestone in its market journey. The stock's recent surge reflects a combination of strong financial results and sustained market outperformance, underscoring the company’s solid position within its industry.

Titan Biotech Ltd has emerged as a standout performer in the Specialty Chemicals sector, delivering multibagger returns of over 224% in the past year alone. This remarkable growth far outpaces the Sensex’s modest 3.22% gain over the same period, underscoring the company’s robust fundamentals and market momentum. Investors and analysts alike are closely examining the drivers behind this surge and assessing the sustainability of its impressive trajectory.

Titan Biotech Ltd is rated Buy by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Titan Biotech Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Titan Biotech Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 February 2026, providing investors with the most recent and relevant data to assess the company’s prospects.